Diagnostic Significance of Proinflammatory Cytokines in Planning Dental Implantation in Patients with General Somatic Pathologies

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

INTRODUCTION: The current stage of development of dental implantology permits to perform a complete dental rehabilitation even in complicated clinical situations. However, there are some difficulties which prevent achievement of a high success of implantological treatment in certain somatic pathologies that manifest in the form of systemic inflammation, and present relative contraindications for implantation. Important general somatic pathologies include chronic obstructive pulmonary disease, atherosclerosis, non-insulin-dependent diabetes mellitus, osteoporosis, etc., they are associated with the risk of acute inflammatory response of an organism to surgical implantological intervention. The risk of unpredictable complications also increases because of insufficiently wide laboratory diagnostic spectrum for planning dental implantation that includes a biochemical blood test, coagulogram, reaction to the presence of specific infections and viral diseases. This list of diagnostic data is not always sufficient for a complete prognosis of success of planned treatment in patients with a complicated general somatic or dental status. Besides, the interrelation between dental chronic diseases and general somatic pathologies which in some cases have common etiopathogenetic factors, is often not taken into account, but without the adequate diagnostic range they often remain unnoticed and lead to persistent complications in different periods after completion of treatment. Development of technologies of surgical and orthopedic dentistry permits to provide full dental care to patients even with different pathologies of organs and systems. But in this case, of importance is extended laboratory diagnostics aimed at identification of factors of chronic systemic inflammation, vascular risk, bacterial threats, for example, evaluation of some interleukins, tumor necrosis factor, C-reactive protein.

CONCLUSION: A complex of clinical, laboratory and instrumental diagnostic methods will permit to adequately evaluate risk for treatment failure and construct a prognostic tactics of complex therapy, thereby reducing the probability for unpredictable complications in dental implantation in patients with different somatic pathologies.

Full Text

ABBREVIATION LIST

CRP — С-reactive protein

CVS — cardiovascular system

DI — dental implantation

DM — diabetes mellitus

hs — high sensitive

IL — interleukin

MFR — maxillofacial region

TNF-α — tumor necrosis factor-α

VEGF — vascular endothelial growth factor

INTRODUCTION

A modern protocol of planning dental implantation permits to exactly predict success of treatment in almost any clinical situation [1]. However, a number of general somatic factors not taken into account in preparation for the operation, give a certain percent of failures in treatment. Later, it may be manifested in the failure of osseointegration, peri-implantitis, implant rejection reactions. These complications can unpredictably emerge in the clinically favorable, at first sight, conditions for osseointegration [2]. Some parameters of the general somatic condition of a patient are not included in the protocol of obligatory examinations before the operation, but, nevertheless, they may be an important characteristic that can point out a key risk factor for failure of implantation.

The process of osseointegration of the implant is a certain structural and functional type of connection between the bone tissue and the implant surface, which ensures its biological stability. The essence of the biological stability of the implant is the formation of new bone tissue and its restructuring (remodeling) in different periods of the implant functioning. However, subtle morphological osteogenic processes can be disrupted by the local or systemic inflammatory factors. In case of a local inflammatory focus, identification of a factor that can affect the successful bone implant integration, is a simple diagnostic task, because modern radiation and other physical diagnostic methods permit to accurately visualize the picture and consequences of inflammatory foci in the maxillofacial region (MFR). A more threatening complication is a systemic inflammatory reaction, which starts at the level of organ systems, being a general somatic pathology. In this case, there are a lot more causes and initiators for the development of such a complication than for local inflammation within the MFR. Often, it is impossible to suspect a general somatic factor of potential complications in routine dental practice due to the insufficient width of the laboratory diagnostic spectrum for planning dental implantation (DI), which includes biochemical blood analysis, coagulogram, reactions to the presence of specific infections and viral diseases [3].

At the stage of taking history and on suspicion of systemic pathologies, the patient may be referred to additional diagnostics, including determination of the level of C-reactive protein (CRP) and proinflammatory cytokines (interleukins (IL), tumor necrosis factor-α (TNF-α)), analysis of the leukocyte formula; however, these examinations are not included in the list of obligatory procedures. In addition, in the available literature, it is not possible to find specific diagnostic protocols and clinical recommendations for planning DI in cases of existence of some underlying somatic pathologies, including chronic systemic inflammation. Often, many general somatic conditions that potentially threaten with the development of the acute phase of inflammation are considered a contraindication for DI, however, there exists a certain percentage of patients who need this modern type of treatment. In this case, the operation can also be performed, but with due consideration of an expanded clinical, instrumental and laboratory diagnostic protocol, which will permit to adequately assess the risk of treatment failure and construct a prognostic tactics of comprehensive therapy.

Systemic inflammatory processes can be identified by determination of the level of certain markers. One of these is CRP, which is a protein of the acute phase of inflammation. In this condition, its concentration in blood plasma dramatically increases by on average 10-100 times. The amount of CRP also correlates with the dynamics of the inflammatory process, the extent of tissue damage. Another feature of CRP is its production by macrophages directly in the focus of inflammation, which is important for the local diagnosis of early postoperative inflammatory phenomena [4]. In this regard, from the point of view of laboratory diagnostics, CRP is one of the most sensitive parameters. Besides, in different injuries, the concentration of CRP can actively rise as early as within the first 6-8 hours, which is also true for surgical interventions in the head and neck performed with a different degree of invasion, especially in reconstructive surgeries in the MFR using endoprosthetics in combination with tooth extraction and, for example, with immediate DI. An increase in the concentration of CRP in such cases is a response of the body aimed at the cellular organization of the inflammation process, localization of the lesion and restoration of the functional ability of tissues of different morphology.

Concentration of CRP can be evaluated by taking serum or blood plasma with further application of the method of radial immunodiffusion or highly sensitive immunoturbidimetry with latex enhancement, the latter method is mainly used for the determination of high sensitive (hs) CRP. In this case, the concentration of CRP is evaluated already at the level of 0.05 mg/l to 10 mg/l [4]. This type of examination is important not so much for making a diagnosis, but rather for determining the level of predictors of a particular pathology or groups of pathologies, which permits to obtain a quantitative parameter of the relative risk of developing the disease. Thus, even for non-extensive surgical intervention in the oral cavity, which may be a single tooth extraction or DI with a minimally invasive protocol, it is possible to preliminarily predict the peculiarities and severity of the body's inflammatory response. In case of dental interventions, one of the fundamental factors of successful treatment is the preserved volume of jaw bone tissue suitable for implantation and further prosthetics, CRP in this case can be a marker of the processes of mineralization and demineralization of bone tissue, which can also be a prognostic factor [4].

Besides changes in the concentration of CRP in the blood, it also appears in the oral fluid after production by hepatocytes in case of tissue damage or inflammation. CRP reaches maximal concentration in the oral cavity on average in 24 hours after synthesis. [5]. Thus, in an obtained sample of the oral fluid, concentration of CRP in it can be determined in immunoenzyme or turbidimetric analysis [4].

Other highly sensitive diagnostic markers are proinflammatory cytokines (IL, TNF-α): IL-1, IL-2, IL-6, IL-8, TNF-α [6]. The listed cytokines may increase systemically in the blood or locally, for example, in the oral fluid. Cytokines are antigen-nonspecific protection factors that provide a local immune inflammatory response. The pathogenetic role of proinflammatory cytokines in patients who underwent dental implant surgery is that when the balance of pro- and anti-inflammatory cytokines is disturbed, there is a risk of impaired osseointegration and the development of destructive processes in the peri-implantation zone [7]. Uncontrolled changes in the cytokine system indicate enhancement in inflammatory and destructive processes in the oral cavity and MFR [8]. In inflammatory phenomena, surgical interventions, or a systemic inflammatory reaction that has manifestations in the oral cavity, cytokines are produced by lymphocytes and macrophages, as well as due to the release of serum transudate and salivary gland secretion into the oral cavity. Besides the local determination of quantitative parameters of proinflammatory cytokines in chronic diseases of the dental system, for example, in chronic periodontitis, this laboratory diagnosis can also be useful in a relatively normal dental status, which can often be complicated by systemic inflammatory reactions of the body in somatic diseases or dermatological pathologies, as, for example, in lichen planus, vulgar pemphigoid, bullous pemphigoid, or in autoimmune diseases of the oral mucosa [9].

Concentration of CRP, as a rule, changes in chronic inflammatory states, and any new intervention can provoke an acute response of an organism, which may often happen in case of DI. For example, a chronic systemic inflammation is one of manifestations of chronic obstructive pulmonary disease and is characterized by inflammatory reactivity of endotheliocytes, as well as of cellular factors of connective tissue [10]. These patients have increased blood levels of CRP, neutrophils, IL-1, IL-2, IL-6, IL-8, TNF-α, which may influence the outcome of different interventions, prognosis for early complications [11] and the quality of DI performed. In the pathogenesis of such changes, a significant role is played by oxidative stress associated with production of excessive amounts of reactive oxygen species or oxygen radicals, which in turn, are one of the of factors of chronic systemic inflammation. With this, there is a wide spread of chronic pulmonary obstructive disease in the population including the category of dental patients.

Another numerous group of patients where chronic systemic inflammation is noted, are patients with obesity, many of which fall into the most common risk groups: those with cardiometabolic syndrome, insulin resistance, endothelial dysfunction, disorders of fibrinolysis and many others [12]. Despite different severity of somatic diseases, such patients also need dental care with application of modern methods of treatment including DI.

According to the research data, the degree of obesity has certain correlations with loss of teeth which is noted in 31% of such patients [13]. One of the main pathogenetic mechanisms of development of chronic inflammation in patients with obesity is increase in the level of proinflammatory adipocytes secreting proinflammatory cytokines (adipokines), such as TNF-α and IL-6 [14] which stimulate production of CRP by the liver cells. This process may induce alterations in the immune response of an organism, and production of TNF-α in this case may stimulate production of osteoclasts. Besides, it is pointed out that overweight patients especially those with abdominal obesity and insulin resistance, practically always have systemic chronic inflammation [15], and metabolic dysregulations of the level of insulin are closely interrelated with metabolism in the bone tissue [16], which is a critical parameter in prognosis of successfulness of DI. Since the patients with obesity relatively often face the problem of chronic periodontal diseases, they are also at risk of development of such complication after DI as peri-implantitis. This is associated with factors of metabolic disorders, increase in the level of peroxide oxidation products and reduction of antioxidant substance, which contributes to chronic inflammation and different kind of tissue destruction [17].

A problem of development of peri-implantitis and its association with obesity is also demonstrated by the results of different studies. Thus, in obese patients, more expressed changes in the dental status are observed, manifested in a tendency to alterations of the bone tissue in the implantation area in the form of resorption, as well as a tendency to clinical disorders in the gingival margin in the region of implants and their suprastructures, which found correlation with increase in the concentration of IL-1β and IL-6 in saliva [18]. Thus, this category of patients are also at risk of development of acute phase reactions and launching of destructive alterations in the bone tissue in case of surgical interventions, which should be taken into account in laboratory diagnostics of the patient at the stage of planning DI.

Patients with excessive weight often have other problems with metabolism, for example, diabetes mellitus (DM) in history. Uncompensated DM is considered an absolute contraindication for DI, however, compensated non-insulin-dependent DM is only a relative contraindication. Here, it has been established that with the adequate metabolic control, the successfulness of DI and the condition of tissue in the region of osseointegration of the implant in patients with DM are not inferior to those of healthy individuals [19]. An importance of monitoring patients with DM is associated with the role of insulin in metabolic processes in the bone tissue, in particular, with its ability to maintain the functional condition of osteoblasts, interrelation with tissue growth factors, ability to stimulate production of hyaluronic acid and collagen synthesis [20]. In management of this group of patients, special attention should be paid to metabolic and biochemical control which may also include determination of concentration of CRP in blood as a marker of systemic inflammation often accompanying patients with DM.

General somatic metabolic pathologies are also reflected in the periodontal diseases, for example, in those associated with DM [21]. These pathological periodontal alterations result from elevation of glucotoxicity level in blood and gingival fluid associated with a dramatic increase in the level of proinflammatory cytokines. In this context, the important role in the pathogenesis and diagnosis in patients with an interrelated dental and somatic pathology is played by IL-1, IL-6, TNF-α.

Patients with chronic periodontal diseases who are not at risk by the parameters of their general somatic status may also face situations of increased levels of markers of the acute phase of inflammation and proinflammatory cytokines, for example, IL-1ß, IL-6, IL-8, which can be isolated in examination of the gingival fluid. The main role in the pathogenesis of development of essential periodontitis or periodontitis associated with somatic pathology, is played by immunocompetent cells: neutrophils, lymphocytes, macrophages. Activation of the cellular defense system and the launch of the cytokine cascade, as a rule, occur in response to a microbial pathogenic factor represented by gram-negative periodontopathogenic obligate or facultative anaerobes of the 1st and 2nd order [22]. In addition, it was also found that in peri-implantitis not associated with systemic inflammation, the level of CRP, IL-1β, IL-6, IL-8, as well as of TNF-α in the gingival fluid and blood serum also tends to increase, which already evidences a local chronic inflammation [23]. Thus, cytokine markers are a universal tool permitting to pinpoint the key risk zones for the development of different dental pathologies and to predict probable inflammatory and destructive events during different surgical interventions in the MFR and oral cavity.

A borderline risk group of patients similar to the previous group with obesity, is a group with diseases of the cardiovascular system (CVS) which are in necessity for dental care due to chronic periodontal diseases, and also due to absence of teeth. Thus, 7.3% of the total amount of dental patients with chronic periodontal diseases have different forms of diseases of CVS [24]. Here, it is pointed out that patients with chronic periodontitis have a potentially higher risk of development of cardiovascular diseases [25]. This can be explained by the metabolic changes of the common nature in an organism, which create different risk factors for development of organ pathologies on the local and systemic levels, for example, the phenomenon of oxidative stress [26]. Thus, generalized periodontal diseases and cardiovascular diseases have the following common manifestations: metabolic syndrome including arterial hypertension, disorder in lipid metabolism [27]. As was said above, the course of periodontitis is characterized by active production of proinflammatory cytokines, with actively increasing concentration of IL-1β IL-6, TNF-α that can influence metabolism of lipids and provoke hyperlipidemia [27]. This is associated with increase in the level of CRP and fibrinogen, which conditions the development of systemic inflammatory response influencing the state of the vascular endothelium.

This creates the probability for development of endothelial dysfunction associated with the systemic inflammation affecting the state of the vascular endothelium [28, 29] and occurring in response to invasion of toxins and antigens produced by periodontopathogenic microorganisms. The pathogenetic factor of the cardiovascular system consists in increasing risk of development of atherosclerotic diseases associated with the systemic inflammation [30]. Infectious threat of the periodontium and related elevation of the inflammation markers may be due to atherosclerosis (including the risk of myocardial infarction) and diseases of peripheral vessels. Thus, in examination of atherosclerotic plaques by immunoenzyme assay, periodontal bacteria were detected in their composition [31].

Currently, new integral parameters of the dental status are used that evaluate its connection with somatic pathologies. N. A. Yudina and L. I. Leus proposed a risk index for chronic oral sepsis, which can be used to summate the foci of chronic infection in the oral cavity and make a prognosis for the development of chronic oral sepsis with evaluation of its influence on the development of somatic pathologies [32]. According to the authors’ data, in evaluation of the risk of oral sepsis and manifestations of somatic pathologies it was found that among the patients with high index values, the percentage of patients with somatic diseases, in particular, with cardiovascular diseases, was higher, and with the medium index values in the age group of 45–54 years, 10% of patients had pathology of CVS.

Thus, it is possible to trace the key general mechanisms of the pathogenesis of systemic pathologies, including cardiovascular diseases and chronic diseases of the dental system, especially of chronic dental odontogenic inflammatory processes, which undoubtedly require active surgical and orthopedic treatment. With this, the diagnostic role of the above described proinflammatory cytokines increases in the given case, since it permits to evaluate the risks of development of different comorbid complications often having an interrelated genesis.

Relative contraindications for DI include the primary or secondary osteoporosis. However, in cases when this pathology does not have any significant manifestations and signs of progression in the MFR, DI is possible, but in a somewhat limited amount, for example, with use of minimally invasive techniques. The development of secondary osteoporosis, according to statistical data, is in most cases associated with chronic diseases of the pulmonary system, including extrapulmonary manifestation of the obstructive pulmonary disease, as well as with DM, where the accumulation of glycation products decreases the activity of osteoblasts and increases that of osteoclasts leading to resorption of the bone tissues [20]. Moreover, it is pointed out that in such cases osteoporosis develops due to systemic inflammation being a manifestation of the above mentioned diseases with the active production of proinflammatory cytokines TNF-α and IL-6, provoking formation of osteoclasts [33], therefore there exists a certain relationship between the processes of bone remodeling and systemic inflammation. Here, DI is also conducted in patients at risk due to osteoporosis. Some large clinical studies refute the claims of osteoporosis directly affecting the failure of DI and the loss of implants [34, 35]. Thus, in this category of patients in case of secondary osteoporosis due to the underlying chronic inflammation, with the appropriate control of the proinflammatory cytokines, as well as of biochemical parameters of systemic inflammation, it is possible to form a fairly accurate prognosis for success of DI and long-term survival of implants.

Biochemical parameters of systemic or local inflammatory reaction are also actively evaluated in patients who need extensive surgical interventions in MFR, often together with DI. Indications for surgical interventions can be inflammatory and non-inflammatory diseases of MFR including oncological ones. A common problem requiring surgical treatment, is an oroantral fistula which can form in result of perforation of the bottom of the maxillary sinus during tooth extraction. This kind of maxillary defect may often be caused by other factors, including otorhinolaryngological ones, for example, maxillary sinusitis, perforated forms of which account for 42%–77% of all diseases of MFR [36]. Thus, the dynamics of postoperative period and probable inflammatory complications after surgical interventions for closure of oroantral fistula, were evaluated by the biochemical parameters of the oral fluid with determination of CRP level [37]. The laboratory analysis of the biochemical inflammation markers in the given surgical interventions performed by dental surgeons jointly with ENT doctors, permits to effectively evaluate the extent of lesion of the sinus mucosa and determine the amount of surgical interventions [37]. In the given case, the main diagnostic parameters are CRP and procalcitonin, obtained from the oral fluid and mixed saliva [38]. His permits to monitor the postoperative period for inflammatory complications with high sensitivity.

Another group of MFR pathologies is a group of pathologies of the oncological genesis which often require invasive surgical intervention. In this case, a detailed analysis of somatic status and of patient’s history, as well as evaluation of the dynamics of the oncological disease are important for correct selection of the tactics of surgical, conservative and radiological treatment. From the point of view of the pathogenesis, carcinogenesis may be triggered by a progressive chronic inflammation. Here, of diagnostic significance are proinflammatory cytokines: TNF-α, IL-1β, IL-6, IL-8, which, along with their participation in the inflammation process, suppress cell apoptosis and launch proliferation, stimulate pathological neoangiogenesis through the vascular endothelial growth factor (VEGF), and metastasis of the neoplasm [39]. Insufficient depth of diagnosis and of differential diagnosis may result in overlooking the true pathology. In such cases, a specialist pays attention only to clinical symptoms of the chronic inflammation, for example, peri-implantitis in the dental implant area or advanced generalized periodontitis, but lack of comprehensive data does not permit to adequately elicit the main cause, a form and stage of progression of pathology. These conclusions are reflected in some foreign scientific studies [40, 41].

CONCLUSION

Based on the above stated peculiarities of the factors of different systemic and organ pathologies, it is possible to trace the importance of comprehensive evaluation of different biochemical parameters of inflammation in planning dental implantation surgery and other kinds of dental treatment of the bone and soft tissues of the maxillofacial region.

The close relationship of markers of chronic inflammation, such as interleukins 1, 2, 6, 8, tumor necrosis factor-α, C-reactive protein, permit to identify the borderline key peculiarities of the pathogenesis of different general somatic and dental pathologies and, on this basis, to more accurately predict success of treatment. This confirms the value of the listed biochemical and immunological parameters of blood or mixed saliva at the stage of diagnosis in dental patients, a significant part of whom have underlying somatic diseases that can influence the success of dental treatment. Just as general somatic diseases have an impact on dental status, chronic inflammatory processes in the maxillofacial region and oral cavity can affect the overall health status.

In this connection, in planning comprehensive dental treatment, attention should be given not only to local dental symptoms, but also to general history data and data of laboratory diagnostics, which will permit to improve the quality of dental treatment and to timely identify pathological interinfluence of comorbid processes, to maintain the general status of the health of the population.

ADDITIONALLY

Funding. This article was not supported by any external sources of funding.

Conflict of interests. The authors declare no conflicts of interests.

Contribution of the authors: A. V. Gus'kov, A. A. Nikiforov — research concept and design, text writing; M. A. Abdurakhmanova, A. A. Oleynikov — collection and processing of material, writing the text; A. S. Kokunova — conception and editing. The authors confirm the correspondence of their authorship to the ICMJE International Criteria. All authors made a substantial contribution to the conception of the work, acquisition, analysis, interpretation of data for the work, drafting and revising the work, final approval of the version to be published and agree to be accountable for all aspects of the work.

×

About the authors

Aleksandr V. Gus'kov

Ryazan State Medical University

Email: guskov74@gmail.com
ORCID iD: 0000-0002-9793-7654
SPIN-code: 3758-6378

MD, Cand. Sci. (Med.), Associate Professor

Russian Federation, Ryazan

Mariyat A. Abdurakhmanova

Ryazan State Medical University

Email: mariyat_2017@mail.ru
ORCID iD: 0000-0001-9944-0214
SPIN-code: 1295-0165

студент

Russian Federation, Ryazan

Aleksandr A. Nikiforov

Ryazan State Medical University

Email: alnik003@yandex.ru
ORCID iD: 0000-0003-0866-9705
SPIN-code: 8366-5282

MD, Cand. Sci. (Med.), Associate Professor

Russian Federation, Ryazan

Aleksandr A. Oleynikov

Ryazan State Medical University

Author for correspondence.
Email: bandprod@yandex.ru
ORCID iD: 0000-0002-2245-1051
SPIN-code: 5579-5202

PhD-Student

Russian Federation, Ryazan

Anzhela S. Kokunova

Ryazan State Medical University

Email: kokunova1977@mail.ru
ORCID iD: 0000-0003-3644-4191
SPIN-code: 9532-6012

MD, Cand. Sci. (Med.)

Russian Federation, Ryazan

References

  1. Durnovo EA, Chekareva II, Grekhov AV, et al. Trust–Based Relationship between Patient and Doctor as Guaranty of Successful Management of Dental Implantation Complications. Nauka Molodykh (Eruditio Juvenium). 2022;10(1):91–100. (In Russ). doi: 10.23888/HMJ202210191-100
  2. Gus’kov AV, Oleinikov AA, Domashkevich NS, et al. Possibilities and prospects for experimental and clinical instrumentation techniques for determining the primary stability of dental implants in comparative analysis. Stomatologiya. 2022;101(1):96–102. (In Russ). doi: 10.17116/stomat202210101196
  3. Pokhodenko–Chudakova IO, Karsyuk YV. Substantiation of the research on the development of the system to prognosticate dental implantation outcomes. Analytical literature review. Vestnik of Vitebsk State Medical University. 2014;13(1):6–12. (In Russ).
  4. Velkov VV. C-reactive protein in laboratory diagnostics of acute inflammations and in risks assessments of vascular pathologies. Kliniko-laboratornyy Konsilium. 2008;(2):37–48. (In Russ).
  5. Kozlova MV, Mkrtumyan AM, Belyakova AS. Regulation of bone''s metabolic process under dental implantation procedure. Kremlin Medicine Journal. 2018;(2):30–9. (In Russ).
  6. Kuznetsova OA, Gubanova EI, Shemonayev VI. Tsitokiny kak pokazatel’ mestnogo immunnogo statusa patsiyentov s khronicheskim parodontitom. Lekarstvennyy Vestnik. 2013;7(2):20–5. (In Russ).
  7. Avanesov АМ, Sedov YuG, Balashova МЕ. Pathogenesis of chronic inflammatory processes in the maxillofacial area (peri-implantitis and periodontitis) and squamous cell carcinoma: similarities and differences (review). Head and Neck Tumors. 2019;9(1):79–84. (In Russ). doi: 10.17650/2222-1468-2019-9-1-79-84
  8. Panakhov NA, Makhmudov TG. The levels of circulating cytokines in the early post-implantation period. Kazan Medical Journal. 2017;98(6):938–43. (In Russ). doi: 10.17750/KMJ2017-938
  9. Rabinovich OF, Rabinovich IM, Abramova ES. The role of cytokines and immunoglobulins of the oral fluid in the genesis of autoimmune diseases of the oral mucosa. Stomatologiya. 2019;98(6, Pt 2):42–5. (In Russ). doi: 10.17116/stomat20199806242
  10. Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):71–86. doi: 10.1016/j.ccm.2013.10.004
  11. Busaidi NA. Relationship between Chronic Obstructive Pulmonary Disease (COPD) and C-Reactive Protein (CRP). Madridge J. Intern Emerg Med. 2018;2(2):71–5. doi: 10.18689/mjiem-1000115
  12. Logvinova OV, Poydasheva AG, Bakulin IS, et al. Modern concepts of the pathogenesis of obesity and new approaches to its correction. Obesity and Metabolism. 2018;15(2):11–6. (In Russ). doi: 10.14341/omet9491
  13. Kang J, Smith S, Pavitt S, et al. Association between central obesity and tooth loss in the non-obese people: Results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999–2012. J Clin Periodontol. 2019;46(4):430–7. doi: 10.1111/jcpe.13091
  14. Karakov KG, Kasimova GV, Eremenko AV. The influence of components of the metabolic syndrome on the development of chronic generalized periodontitis. Parodontologiya. 2017;22(1):15–9. (In Russ).
  15. Duzagac E, Cifcibasi E, Erdem MG, et al. Is obesity associated with healing after non-surgical periodontal therapy? A local vs. systemic evaluation. J Periodontal Res. 2016;51(5):604–12. doi: 10.1111/jre.12340
  16. Sabirova AI, Mamytova AB, Murkamilov IT, et al. The mineralization of bone tissue in patients with generalized periodontitis against the background of metabolic syndrome. Rossiiskii Meditsinskii Zhurnal. 2018;24(1):45–9. (In Russ). doi: 10.18821/0869-2106-2018-24-1-45-49
  17. Astashina NB, Plyukhin DV, Sosnin YuD, et al. Salivary level of lipid peroxidation products as a predictor of dental implantation complications. Stomatologiya. 2019;98(3):31–4. (In Russ). doi: 10.17116/stomat20199803131
  18. Abduljabbar T, Al-Sahaly F, Kellesarian SV, et al. Comparison of peri-implant clinical and radiographic inflammatory parameters and whole salivary destructive inflammatory cytokine profile among obese and non-obese men. Cytokine. 2016;88:51–6. doi: 10.1016/j.cyto.2016.08.017
  19. Monje A, Catena A, Borgnakke WS. Association between diabetes mellitus/hyperglycaemia and peri-implant diseases: Systematic review and meta-analysis. J Clin Periodontol. 2017;44(6):636–48. doi: 10.1111/jcpe.12724
  20. Murray CE, Coleman CM. Impact of Diabetes Mellitus on Bone Health. Int J Mol Sci. 2019;20(19):4873. doi: 10.3390/ijms20194873
  21. Petruk IV, Eliseeva EV, Poddubny EA, et al. Problems of anti- bacterial medications use in dental implant placement. Pacific Medical Journal. 2019;(2):51–4. (In Russ). doi: 10.17238/PmJ1609-1175.2019.2.51-54
  22. Kasimov AE, Grigorievskaya Z V, Kropotov MA, et al. Periodontal pathogens as a risk factor for oral squamous cell carcinoma. Head and Neck Tumors. 2021;11(3):83–93. (In Russ). doi: 10.17650/2222-1468-2021-11-3-83-93
  23. Kharaeva ZF, Mustafaeva FM, Mustafaev MSh, et al. Interleukin’s status of patients with periimplantitis. Izvestiya Kabardino-Balkarskogo Nauchnogo Tsentra RAN. 2014;(5):254–7. (In Russ).
  24. Grudyanov AI, Krechina EK, Tkacheva ON, et al. Vzaimosvyaz’ vospalitel’nykh zabolevaniy parodonta s serdechno-sosudistymi zabolevaniyami. Moscow; 2018. (In Russ).
  25. Desvarieux M, Demmer RT, Jacobs DR Jr, et al. Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens. 2010;28(7):1413–21. doi: 10.1097/HJH.0b013e328338cd36
  26. Kondyurova EV, Vlasova TI, Trofimov VA, et al. Condition of platelet factor of hemostasis system in pathogenesis of chronic periodontitis progression. I. P. Pavlov Russian Medical Biological Herald. 2019;27(2):209–18. (In Russ). doi: 10.23888/PAVLOVJ2019272209-218
  27. Trukhan DI, Trukhan LYu. Relationship between periodontal and cardiovascular diseases. International Heart and Vascular Disease Journal. 2016;4(11):15–24. (In Russ).
  28. Strelnikova EA, Trushkina PYu, Surov IYu, et al. Endothelium in vivo and in vitro. Part 1: histogenesis, structure, cytophysiology and key markers. Nauka Molodykh (Eruditio Juvenium). 2019;7(3):450–65. doi: 10.23888/HMJ201973450-465
  29. Kalinin RE, Suchkov IA, Klimentova EA, et al. Markers of apoptosis, cell proliferation, endothelial dysfunction in patients with peripheral atherosclerosis. Bulletin of Pirogov National Medical & Surgical Center. 2021;16(1):29–32. (In Russ). doi: 10.25881/BPNMSC.2021.26.94.005
  30. Hagh LG, Zakavi F, Hajizadeh F, et al. The association between hyperlipidemia and periodontal infection. Iran Red Crescent Med J. 2014;16(12):e6577. doi: 10.5812/ircmj.6577
  31. Shetty D, Dua M, Kumar K, et al. Oral hygiene status of individuals with cardiovascular diseases and associated risk factors. Clin Pract. 2012;2(4):e86. doi: 10.4081/cp.2012.e86
  32. Yudina NA, Leus PA. New Integral Index of Dental Status and Its Use in Research. The Dental Institute. 2010;(1):86–7. (In Russ).
  33. Jadon DR, Nightingale AL, McHugh NJ, et al. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondylo-arthropathy. J Rheumatol. 2015;42(1):21–30. doi: 10.3899/jrheum.140223
  34. Radi IAW, Ibrahim W, Iskandar SMS, et al. Prognosis of dental implants in patients with low bone density: A systematic review and meta-analysis. J Prosthet Dent. 2018;120(5):668–77. doi: 10.1016/j.prosdent.2018.01.019
  35. De Medeiros FCFL, Kudo GAH, Leme BG, et al. Dental implants in patients with osteoporosis: a systematic review with meta-analysis. Int J Oral Maxillofac Surg. 2018;47(4):480–91. doi: 10.1016/j.ijom.2017.05.021
  36. Durnovo EA, Fedorichev AO, Khomutinnikova NE. Modern view on the problem of oroantral fistula closure: literature review. Stomatologiya. 2019;98(2):76–80. (In Russ). doi: 10.17116/stomat20199802176
  37. Morozova MN, Gordienko AI, Demianenko SA, et al. Dynamics of indicators of C-reactive protein and procalcitonin in the oral fluid of patients with plastic oroantral communication. Parodontologiya. 2020;25(3):246–50. (In Russ). doi: 10.33925/1683-3759-2020-25- 3-246-250
  38. Zubachik VM, Boris GZ, Furdychko AI, et al. The biochemical indices of inflammation and dysbiosis in oral fluid (saliva) of hepato-biliary pathology patients. Vestnik Stomatologii. 2017;(3):11–5. (In Russ).
  39. Sahingur SE, Yeudall WA. Chemokine function in periodontal disease and oral cavity cancer. Front Immunol. 2015;6:214. doi: 10.3389/fimmu.2015.00214
  40. Pinchasov G, Haimov H, Druseikaite M, et al. Oral cancer around dental implants appearing in patients withwithout a history of oral or systemic malignancy: a systematic review. J Oral Maxillofac Res. 2017;8(3):e1. doi: 10.5037/jomr.2017.8301
  41. Oh SH, Kang JH, Seo Y–K, et al. Unusual malignant neoplasms occurring around dental implants: A report of 2 cases. Imaging Sci Dent. 2018;48(1):59–65. doi: 10.5624/isd.2018.48.1.59

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies